Norroy Bioscience Co., LTD
6 clinical trials · Sponsor
◉ Watch Norroy Bioscience Co., LTD
| Record | Firm | Date |
|---|---|---|
| Evaluation of Safety, Pharmacokinetics, Distribution，Radiation Safety and Sensitivity/Specificity of PET/CT Imaging With 68Ga-NYM096 in Participants With IRM (NCT07768306) | Norroy Bioscience Co., LTD | 2026-09-01 |
| Investigating the Safety and Diagnostic Performance of 68Ga-NYM032 Injection PET/CT in Men With Newly Diagnosed Prostate Cancer. (NCT07615101) | Norroy Bioscience Co., LTD | 2026-08-06 |
| This Study Evaluates the Diagnostic Performance and Safety of 68Ga-NYM032 PET/CT Imaging in Patients With Suspected Recurrence of Prostate Cancer. (NCT07649122) | Norroy Bioscience Co., LTD | 2026-06-30 |
| Pharmacokinetics, Biodistribution, Radiation Dose and Safety Study of 68Ga-NYM005 in Patients (NCT06389682) | Norroy Bioscience Co., LTD | 2024-06-17 |
| Pharmacokinetics, Biodistribution, Radiation Dose and Safety Study of 68Ga-NYM032 in Patients (NCT06389695) | Norroy Bioscience Co., LTD | 2024-06-04 |
Track Norroy Bioscience Co., LTD automatically
Every clearance here is in the API, with alerts when new ones post.